{"content":"<li class=\"n-box-item date-title\" data-end=\"1496375999\" data-start=\"1496289600\" data-txt=\"Monday, December 23, 2019\">Thursday, June  1, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3271189\" data-ts=\"1496358192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBS\" target=\"_blank\">CBS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271189-appeals-court-stays-fcc-decision-eases-station-owner-buyouts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Appeals court stays FCC decision that eases station-owner buyouts</a></h4><ul>     <li>A federal appeals court has <a href=\"http://www.broadcastingcable.com/news/washington/federal-court-stays-fcc-uhf-discount-decision-now/166250\" target=\"_blank\">stayed the FCC's vote</a> reinstating the \"UHF discount\" -- a move that eases restrictions on station ownership and is widely seen to ease broadcast station owner acquisitions.</li>     <li>The move is an administrative stay that just gives the court time to look at arguments it's receiving this week from opposing sides.</li>   <li>But the ruling comes ahead of an expected June 5 return of the discount, a foregone conclusion that led to Sinclair Broadcast Group's (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color='green'>+3.7%</font>) <a href=\"https://seekingalpha.com/news/3264552-sinclair-broadcast-announces-3_9b-deal-tribune-media\" target=\"_blank\">move to buy Tribune Media</a> (<a href=\"http://seekingalpha.com/symbol/TRCO\" target=\"_blank\">TRCO</a> <font color='green'>+0.6%</font>) for $3.9B. Now that effective date for the discount's return is in doubt.</li>     <li>Other station owners: CBS (NYSE:<a href='https://seekingalpha.com/symbol/CBS' title='CBS Corporation'>CBS</a>), Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>), Nexstar Media Group (NASDAQ:<a href='https://seekingalpha.com/symbol/NXST' title='Nexstar Media Group, Inc.'>NXST</a>).</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3258410-fcc-oks-tv-ownership-rule-ease-buyouts\" target=\"_blank\">FCC OKs TV ownership rule that should ease buyouts</a> (Apr. 20 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271189\" data-linked=\"Appeals court stays FCC decision that eases station-owner buyouts\" data-tweet=\"$CBS $VIAC $FOX - Appeals court stays FCC decision that eases station-owner buyouts https://seekingalpha.com/news/3271189-appeals-court-stays-fcc-decision-eases-station-owner-buyouts?source=tweet\" data-url=\"https://seekingalpha.com/news/3271189-appeals-court-stays-fcc-decision-eases-station-owner-buyouts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271184\" data-ts=\"1496355581\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTI\" target=\"_blank\">WTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271184-w-and-t-offshore-ordered-to-pay-43m-judgment-to-apache\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">W&amp;T Offshore ordered to pay $43M judgment to Apache</a></h4><ul><li>W&amp;T&nbsp;Offshore (NYSE:<a href='https://seekingalpha.com/symbol/WTI' title='W&T Offshore, Inc.'>WTI</a>) <font color='red'>-3.4%</font>&nbsp;AH after a final District Court judgment <a href=\"https://seekingalpha.com/pr/16850559-w-and-t-offshore-receives-final-trial-court-judgment-lawsuit\" target=\"_blank\">orders it to pay $43.2M</a> to Apache (NYSE:<a href='https://seekingalpha.com/symbol/APA' title='Apache Corporation'>APA</a>), plus $4.4M in interest, attorney's  fees and other costs.</li><li>The judgment stems from a lawsuit APA filed  in 2014 regarding a dispute about APA's use of drilling  rigs instead of a previously contracted intervention vessel for the  plugging and abandonment of three deepwater wells in the Mississippi Canyon area of the Gulf of Mexico.</li><li>W&amp;T previously paid $24.9M as an undisputed amount for the plug and abandonment work.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271184\" data-linked=\"W&amp;T Offshore ordered to pay $43M judgment to Apache\" data-tweet=\"$WTI $WTI $APA - W&amp;T Offshore ordered to pay $43M judgment to Apache https://seekingalpha.com/news/3271184-w-and-t-offshore-ordered-to-pay-43m-judgment-to-apache?source=tweet\" data-url=\"https://seekingalpha.com/news/3271184-w-and-t-offshore-ordered-to-pay-43m-judgment-to-apache\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271181\" data-ts=\"1496354012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMASY\" target=\"_blank\">IMASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271181-oneweb-looks-to-satellite-mates-after-intelsat-deal-falters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneWeb looks to other satellite mates after Intelsat deal falters</a></h4><ul>   <li>With the <a href=\"https://seekingalpha.com/news/3270872-oneweb-intelsat-merger-collapse\" target=\"_blank\">breakdown of its merger</a> with Intelsat (<a href=\"http://seekingalpha.com/symbol/I\" target=\"_blank\">I</a> <font color='red'>-1.6%</font>) after bondholder opposition to a debt deal, OneWeb, backed by parent SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color='green'>+0.2%</font>), has already begun <a href=\"https://www.bloomberg.com/news/articles/2017-06-01/intelsat-bondholders-said-to-reject-proposed-merger-with-oneweb\" target=\"_blank\">talking with alternative partners</a>, Bloomberg reports.</li>    <li>A source told Bloomberg other prospects for a OneWeb tie-up include Inmarsat (<a href='https://seekingalpha.com/symbol/IMASY' title='Inmarsat Plc. ADR'>OTCPK:IMASY</a>), as well as Telesat Holdings and Luxembourg's SES.</li>    <li>Inmarsat <font color='green'>gained 5.8%</font> in London today (<a href='https://seekingalpha.com/symbol/IMASF' title='Inmarsat Plc.'>OTCPK:IMASF</a> <font color='green'>+7%</font> today), while SES <font color='green'>rose 4.1%</font> in Paris trading.</li>    <li>Though the deal's dead, Intelsat said it would continue to work with OneWeb on its pre-existing deals.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271181\" data-linked=\"OneWeb looks to other satellite mates after Intelsat deal falters\" data-tweet=\"$IMASY $IMASY $IMASF - OneWeb looks to other satellite mates after Intelsat deal falters https://seekingalpha.com/news/3271181-oneweb-looks-to-satellite-mates-after-intelsat-deal-falters?source=tweet\" data-url=\"https://seekingalpha.com/news/3271181-oneweb-looks-to-satellite-mates-after-intelsat-deal-falters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271177\" data-ts=\"1496352978\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271177-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+15.5%</font>. <a href='https://seekingalpha.com/symbol/SGYP' title='Synergy Pharmaceuticals, Inc.'>SGYP</a> <font color='green'>+5.2%</font>. <a href='https://seekingalpha.com/symbol/CNSL' title='Consolidated Communications Holdings, Inc.'>CNSL</a> <font color='green'>+3.5%</font>. <a href='https://seekingalpha.com/symbol/BG' title='Bunge Limited'>BG</a> <font color='green'>+3.4%</font>. <a href='https://seekingalpha.com/symbol/NBR' title='Nabors Industries Ltd.'>NBR</a> <font color='green'>+2.8%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a> <font color='red'>-23.2%</font>. <a href='https://seekingalpha.com/symbol/BOOT' title='Boot Barn Holdings'>BOOT</a> <font color='red'>-16.4%</font>. <a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color='red'>-8.0%</font>. <a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a> <font color='red'>-7.6%</font>. <a href='https://seekingalpha.com/symbol/AAN' title='Aaron&#39;s Inc.'>AAN</a> <font color='red'>-3.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271177\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$LULU $SGYP-OLD $CNSL - After Hours Gainers / Losers https://seekingalpha.com/news/3271177-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3271177-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271173\" data-ts=\"1496351510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VMW\" target=\"_blank\">VMW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271173-vmware-beats-q1-estimates-shares-down-4_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VMware beats Q1 estimates, shares down 4.5%</a></h4><ul><li>        VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>) Q1 report beat EPS and revenue estimates. Operating cash flows were $775M, FCF was $726M, and the company reported $8.6B in cash and equivalents.</li><li>               License revenues were $610M, up 7% from the prior year&rsquo;s quarter excluding the impact of unearned revenue related to the sale of vCloud Air to OVH Group.&nbsp;</li><li>           VMware shares are&nbsp;<font color='red'>down 4.52%</font>&nbsp;aftermarket.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3271141-vmware-beats-0_04-beats-revenue\" target=\"_blank\">VMware beats by $0.04, beats on revenue</a> (June 1)</li></ul> &nbsp;<br /><div class=\"tiny-share-widget\" data-id=\"3271173\" data-linked=\"VMware beats Q1 estimates, shares down 4.5%\" data-tweet=\"$VMW - VMware beats Q1 estimates, shares down 4.5% https://seekingalpha.com/news/3271173-vmware-beats-q1-estimates-shares-down-4_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3271173-vmware-beats-q1-estimates-shares-down-4_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271165\" data-ts=\"1496350379\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWRE\" target=\"_blank\">GWRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271165-guidewire-beats-q3-estimates-guidance-mixed-shares-down-3_3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidewire beats Q3 estimates, guidance mixed; shares down 3.3%</a></h4><ul><li>        Guidewire Software (NYSE:<a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a>) Q3 report beat EPS and revenue estimates. The company had $591.4M in cash and equivalents and generated $21.9M in cash from operations.</li><li>               Segment sales: License and other: $59M (+29% Y/Y); Maintenance: $16.9M (+15%); Services: $47.6M (+24%).&nbsp;</li><li>               Q4 guidance has total revenues between $165.8M and $169.8M and EPS between $0.36 and $0.40. Consensus estimates have revenue and EPS at $179.85M and $0.45, respectively. &nbsp;&nbsp;</li><li>               FY17 guidance includes revenue between $499M and $503M, compared to $496.49M consensus, with $0.82-$0.86 EPS, well above the $0.72 consensus.&nbsp;</li><li>               Guidewire shares are&nbsp;<font color='red'>down 3.28%</font>&nbsp;aftermarket.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>        <a href=\"https://seekingalpha.com/pr/16850563-guidewire-software-announces-third-quarter-fiscal-2017-financial-results\" target=\"_blank\">Press Release</a> </li><li>Previously: <a href=\"https://seekingalpha.com/news/3271142-guidewire-software-beats-0_19-beats-revenue\" target=\"_blank\">Guidewire Software beats by $0.19, beats on revenue</a> (June 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271165\" data-linked=\"Guidewire beats Q3 estimates, guidance mixed; shares down 3.3%\" data-tweet=\"$GWRE - Guidewire beats Q3 estimates, guidance mixed; shares down 3.3% https://seekingalpha.com/news/3271165-guidewire-beats-q3-estimates-guidance-mixed-shares-down-3_3?source=tweet\" data-url=\"https://seekingalpha.com/news/3271165-guidewire-beats-q3-estimates-guidance-mixed-shares-down-3_3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271164\" data-ts=\"1496350076\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RETA\" target=\"_blank\">RETA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271164-reata-pharmas-mid-stage-data-on-fa-candidate-omaveloxolone-appear-equivocal-shares-slip-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reata Pharma&#39;s mid-stage data on FA candidate omaveloxolone appear equivocal; shares slip 11% after hours</a></h4><ul><li>Thinly traded micro cap Reata Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/RETA' title='Reata Pharmaceuticals'>RETA</a>) slumps&nbsp;<font color='red'>11%</font>&nbsp;after hours on average volume after it <a href=\"https://seekingalpha.com/pr/16850462-reata-pharmaceuticals-inc-announces-positive-data-part-one-moxie-trial-omaveloxolone\" target=\"_blank\">announced </a>results from Part 1 of its Phase 2 study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02255435?term=moxie&amp;rank=1\" target=\"_blank\">MOXIe</a>, assessing omaveloxolone for the treatment of Friedreich's ataxia &#40;FA&#41;, an inherited disorder characterized by the progressive loss of coordination and eventually morbidities like diabetes and heart disease.</li><li>Part 1 randomized 69 FA patients to receive one of seven different doses of omaveloxolone or placebo for 12 weeks. It assessed pharmacodynamic and neurological effects but was not powered to demonstrate efficacy.</li><li>Nevertheless, investors appear underwhelmed with the results. The company says the study showed treatment with omaveloxolone was \"associated with improvements in mitochondrial and neurological function.\" And, dose-dependent and time-dependent effects on an FA rating scale (mFARS) were \"observed at pharmacodynamically active doses.\"</li><li>The treatment benefit appeared to be most pronounced in a subgroup of FA patients without a foot deformity called <em>pes cavu</em>s (high arched feet). The improvement in mFARS was statistically significantly better than placebo. Across all patients, omaveloxolone did not improve peak work as measured during the maximal exercise test, the primary endpoint.</li><li>The company plans to initiate Part 2 of MOXIe in H2.</li><li>Omaveloxolone is an <a href=\"https://reatapharma.com/our-science/nrf2-activators/\" target=\"_blank\">antioxidant inflammation modulator</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271164\" data-linked=\"Reata Pharma&#39;s mid-stage data on FA candidate omaveloxolone appear equivocal; shares slip 11% after hours\" data-tweet=\"$RETA - Reata Pharma&#39;s mid-stage data on FA candidate omaveloxolone appear equivocal; shares slip 11% after hours https://seekingalpha.com/news/3271164-reata-pharmas-mid-stage-data-on-fa-candidate-omaveloxolone-appear-equivocal-shares-slip-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3271164-reata-pharmas-mid-stage-data-on-fa-candidate-omaveloxolone-appear-equivocal-shares-slip-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271158\" data-ts=\"1496349194\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARS\" target=\"_blank\">CARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271158-cars-com-finishes-first-day-spin-off-on-high-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cars.com finishes first day as spin-off on high note</a></h4><ul>   <li>With a closing-minutes spike, Cars.com (NYSE:<a href='https://seekingalpha.com/symbol/CARS' title='Cars.com Inc.'>CARS</a>) finished <font color='green'>up 7.8%</font> its first day of trading as an independent entity.</li>    <li>The unit spun off from broadcast-oriented parent Tegna (NYSE:<a href='https://seekingalpha.com/symbol/TGNA' title='TEGNA'>TGNA</a>) last month; Gannett had bought out other owners that held Cars.com in 2014, and Tegna itself spun off from Gannett in 2015.</li>    <li>With the spin-off final, Tegna CEO Gracia Martore retires and exits the board, to be succeeded by former Tegna Media chief Dave Lougee.</li>    <li>Tegna's digital unit, which included Cars.com and CareerBuilder, drew revenues of $1.4B last year; Cars.com drew a little over $600M of that.</li>    <li>Cars.com has forecast that sales growth will likely be flat this year before gaining 5-10% in 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271158\" data-linked=\"Cars.com finishes first day as spin-off on high note\" data-tweet=\"$CARS $CARS $TGNA - Cars.com finishes first day as spin-off on high note https://seekingalpha.com/news/3271158-cars-com-finishes-first-day-spin-off-on-high-note?source=tweet\" data-url=\"https://seekingalpha.com/news/3271158-cars-com-finishes-first-day-spin-off-on-high-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271150\" data-ts=\"1496348679\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDAY\" target=\"_blank\">WDAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271150-workday-beats-q1-estimates-shares-down-2_7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workday beats Q1 estimates, shares down 2.7%</a></h4><ul><li>Workday (NYSE:<a href='https://seekingalpha.com/symbol/WDAY' title='Workday'>WDAY</a>) Q1 report beat EPS and revenue estimates. Subscription revenues were up 42.7% to $399.7M. &nbsp;Other key metrics include $61M operating profit, $180M operating cash flow, $149.4M, and $2.1B in cash and equivalents.</li><li>Q2 guidance puts subscriber revenue between $420M and $423M for an up to 38% growth over the prior year&rsquo;s quarter.</li><li>FY18 guidance was raised to $1.705B to $1.270B in subscription revenue, which would represent an up to 33% growth on the year. Consensus estimates have revenue at $2.02B for overall revenue.</li><li>Workday shares are&nbsp;<font color='red'>down 2.7%</font>&nbsp;aftermarket.</li><li><a href=\"https://seekingalpha.com/pr/16850522-workday-announces-fiscal-2018-first-quarter-financial-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3271133-workday-beats-0_13-beats-revenue\" target=\"_blank\">Workday beats by $0.13, beats on revenue</a> (June 1)</li></ul> <em>Correction: A previous version of this article misstated the FY18 guidance as total revenue rather than subscription revenue.&nbsp;</em><div class=\"tiny-share-widget\" data-id=\"3271150\" data-linked=\"Workday beats Q1 estimates, shares down 2.7%\" data-tweet=\"$WDAY - Workday beats Q1 estimates, shares down 2.7% https://seekingalpha.com/news/3271150-workday-beats-q1-estimates-shares-down-2_7?source=tweet\" data-url=\"https://seekingalpha.com/news/3271150-workday-beats-q1-estimates-shares-down-2_7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271147\" data-ts=\"1496348475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RH\" target=\"_blank\">RH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271147-rh-craters-after-guidance-arrives-light\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RH craters after guidance arrives light</a></h4><ul> <li>RJ (NYSE:<a href='https://seekingalpha.com/symbol/RH' title='RH'>RH</a>) falls sharply in AH trading after guidance disappoint.</li> <li>Comparable brand revenue was up 9% Y/Y, but concerns over RH's margins are front and center with investors. \"While our higher outlet sales and inventory optimization efforts had a positive impact on revenues in the first quarter, these sales, plus related mark-downs and inventory reserves, had a negative impact on margins and earnings,\" notes CEO Gary Friedman.</li><li>RH sees full-year EPS falling in a range of $1.67 to $1.94 vs. $2.15 consensus.</li> <li>RH <font color='red'>-21.45%</font> AH to $44.97.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3271147\" data-linked=\"RH craters after guidance arrives light\" data-tweet=\"$RH - RH craters after guidance arrives light https://seekingalpha.com/news/3271147-rh-craters-after-guidance-arrives-light?source=tweet\" data-url=\"https://seekingalpha.com/news/3271147-rh-craters-after-guidance-arrives-light\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271145\" data-ts=\"1496348309\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271145-broadcomplus-3-fiscal-q2-profits-beat-best-street-estimate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom +3% as fiscal Q2 profits beat best Street estimate</a></h4><ul>   <li>Broadcom (<a href=\"http://seekingalpha.com/symbol/AVGO\" target=\"_blank\">AVGO</a> <font color='red'>-2%</font>) has <font color='green'>gained 3%</font> after hours, again nearing its 52-week high, after swinging to a net gain and beating the highest Street profit estimate in <a href=\"https://seekingalpha.com/news/3271123-broadcom-beats-0_19-beats-revenue\" target=\"_blank\">fiscal Q2 results</a>.</li>    <li>Net income of $464M compared to a year-ago net loss of $1.255B. Operating inome was $474M, vs. last year's operating loss of $1B.</li>    <li>Gross margin was $1.976B, 47.2% of net revenue, vs. 29.5% a year ago.</li>    <li>Revenue by segment: Wired infrastructure, $2.11B (up 2%); Wireless communications, $1.15B (up 45%); Enterprise storage, $712M (up 36%); Industrial and other, $217M (up 32%).</li>    <li>Cash came to $4.25B vs. the previous quarter's $3.54B.</li>    <li>Expecting \"healthy\" end markets, for its fiscal Q3 the company's forecasting net revenues of $4.375B-$4.525B (above consensus for $4.265B), gross margin of 62-64%, and operating expenses of $787M. Revenue gains will be \"driven by solid growth from our wired segment and a seasonal second half ramp in our wireless segment.&rdquo;</li>    <li><a href=\"http://edge.media-server.com/m/p/ghpssndn/lan/en\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/16850483-broadcom-limited-announces-second-quarter-fiscal-year-2017-financial-results-interim-dividend\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3271145\" data-linked=\"Broadcom +3% as fiscal Q2 profits beat best Street estimate\" data-tweet=\"$AVGO - Broadcom +3% as fiscal Q2 profits beat best Street estimate https://seekingalpha.com/news/3271145-broadcomplus-3-fiscal-q2-profits-beat-best-street-estimate?source=tweet\" data-url=\"https://seekingalpha.com/news/3271145-broadcomplus-3-fiscal-q2-profits-beat-best-street-estimate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271138\" data-ts=\"1496348065\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271138-lululemon-rallies-after-outlook-improves\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon rallies after outlook improves</a></h4><ul> <li>Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) reports comparable sales fell 1% in <a href=\"https://seekingalpha.com/pr/16850510-lululemon-athletica-inc-announces-first-quarter-fiscal-2017-results-plan-restructure-ivivva\" target=\"_blank\">Q1</a> to top the consensus mark for a 1.9% drop.</li> <li>Gross margin came in at 49.4% of sales vs. 48.8% expected and 48.3% a year ago.</li> <li>Operating margin improved 50 bps to 12.1% of sales during the quarter.</li> <li>\"I'm excited to see the positive trends that materialized late in Q1 continuing into Q2,\" notes Lululemon CEO Laurent Potdevin.</li> <li>Looking ahead, Lululemon sees full-year revenue of $2.53B to $2.58B vs. $2.34B consensus and full-year EPS $1.97 to $2.07 vs. $2.16 consensus.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3271124-lululemon-athletica-beats-0_04-beats-revenue\" target=\"_blank\">Lululemon Athletica beats by $0.04, beats on revenue</a> (June 1)</li> <li>LULU <font color='green'>+10.03%</font> premarket to $53.69.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271138\" data-linked=\"Lululemon rallies after outlook improves\" data-tweet=\"$LULU - Lululemon rallies after outlook improves https://seekingalpha.com/news/3271138-lululemon-rallies-after-outlook-improves?source=tweet\" data-url=\"https://seekingalpha.com/news/3271138-lululemon-rallies-after-outlook-improves\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271130\" data-ts=\"1496347691\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVRA\" target=\"_blank\">SVRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271130-savara-readies-equity-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Savara readies equity offering</a></h4><ul><li>Savara (NASDAQ:<a href='https://seekingalpha.com/symbol/SVRA' title='Savara Inc.'>SVRA</a>) <a href=\"https://seekingalpha.com/pr/16850473-savara-announces-proposed-public-offering-common-stock\" target=\"_blank\">launches </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li><li>The company has a pending merger with Mast Therapeutics.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271130\" data-linked=\"Savara readies equity offering\" data-tweet=\"$SVRA - Savara readies equity offering https://seekingalpha.com/news/3271130-savara-readies-equity-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3271130-savara-readies-equity-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271124\" data-ts=\"1496347575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271124-lululemon-athletica-beats-0_04-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon Athletica beats by $0.04, beats on revenue</a></h4><ul><li>Lululemon Athletica (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>): Q1 EPS of $0.32 <font color='green'>beats by $0.04</font>.</li><li>Revenue of $520.3M (+5.0% Y/Y) <font color='green'>beats by $6.38M</font>.</li><li>Shares <font color='green'>+9.9%</font>.</li><li><a href='https://seekingalpha.com/pr/16850510-lululemon-athletica-inc-announces-first-quarter-fiscal-2017-results-plan-restructure-ivivva'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3271124\" data-linked=\"Lululemon Athletica beats by $0.04, beats on revenue\" data-tweet=\"$LULU - Lululemon Athletica beats by $0.04, beats on revenue https://seekingalpha.com/news/3271124-lululemon-athletica-beats-0_04-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3271124-lululemon-athletica-beats-0_04-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271123\" data-ts=\"1496347518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVGO\" target=\"_blank\">AVGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271123-broadcom-beats-0_19-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Broadcom beats by $0.19, beats on revenue</a></h4><ul><li>Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>): Q2 EPS of $3.69 <font color='green'>beats by $0.19</font>.</li><li>Revenue of $4.2B (+18.0% Y/Y) <font color='green'>beats by $90M</font>.</li><li>Shares <font color='green'>+2.26%</font>.</li><li><a href=\"https://seekingalpha.com/pr/16850483-broadcom-limited-announces-second-quarter-fiscal-year-2017-financial-results-interim-dividend\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3271123\" data-linked=\"Broadcom beats by $0.19, beats on revenue\" data-tweet=\"$AVGO - Broadcom beats by $0.19, beats on revenue https://seekingalpha.com/news/3271123-broadcom-beats-0_19-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3271123-broadcom-beats-0_19-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271111\" data-ts=\"1496346733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIT\" target=\"_blank\">XBIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271111-xbiotechs-mabp1-shows-significant-treatment-effect-in-late-stage-crc-study-shares-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XBiotech&#39;s MABp1 shows significant treatment effect in late-stage CRC study; shares up 24%</a></h4><ul><li>Thinly traded micro cap XBiotech (<a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+24.4%</font>) jumps on triple normal volume in response to its <a href=\"https://seekingalpha.com/pr/16849525-xbiotech-presents-phase-iii-findings-antibody-therapy-colorectal-cancer-2017-asco-meeting\" target=\"_blank\">release of data</a> from a European Phase 3 study evaluating MABp1 for the treatment of patients with symptomatic refractory metastatic colorectal cancer &#40;CRC&#41;. The results will be presented at ASCO on June 3.</li><li>40% of patients treated with MABp1 achieved the primary endpoint compared to 23% for placebo (p=0.003). Median overall survival in the test group was 11.7 months vs. 5.7 months in patients who did not receive MABp1. 42% of patients treated with MABp1 experienced stable disease compared to 12% for others.</li><li>MABp1 is a&nbsp;<a href=\"http://www.xbiotech.com/true-human/index.html\" target=\"_blank\">True Human</a>&nbsp;monoclonal antibody that binds to (neutralizes)&nbsp;<a href=\"https://en.wikipedia.org/wiki/IL1A\" target=\"_blank\">interleukin-1 alpha</a>, a pro-inflammatory cytokine (protein).</li></ul><div class=\"tiny-share-widget\" data-id=\"3271111\" data-linked=\"XBiotech&#39;s MABp1 shows significant treatment effect in late-stage CRC study; shares up 24%\" data-tweet=\"$XBIT - XBiotech&#39;s MABp1 shows significant treatment effect in late-stage CRC study; shares up 24% https://seekingalpha.com/news/3271111-xbiotechs-mabp1-shows-significant-treatment-effect-in-late-stage-crc-study-shares-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3271111-xbiotechs-mabp1-shows-significant-treatment-effect-in-late-stage-crc-study-shares-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271101\" data-ts=\"1496344439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271101-tenet-and-humana-amend-in-network-access-deal-effective-date-today-thc-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenet and Humana amend in-network access deal, effective date today; THC up 6%</a></h4><ul><li>Tenet Healthcare (<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color='green'>+6%</font>) and Humana (<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a> <font color='green'>+1.2%</font>) <a href=\"https://seekingalpha.com/pr/16850305-tenet-humana-amend-effective-dates-previously-disclosed-agreement-restoring-network-access\" target=\"_blank\">amend </a>their multiyear in-network access agreement phasing all of Tenet's hospitals, hospital-affiliated outpatient centers and clinics back into Humana's network. Effective today, all of Humana's members who have commercial insurance, Medicare, Medicaid or personal insurance bought on an exchange will be considered in-network with all Tenet providers.</li><li>Tenet SVP and Chief Managed Care Officer Clint Hailey says, &ldquo;We are pleased to have revised the terms of our agreement with Humana, which we believe is in the best interests of our patients and the communities we serve. We look forward to once again serving as a trusted provider of high-quality care for Humana members nationwide.&rdquo;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3261891-tenet-healthcare-plus-14-percent-beat-humana-hca-deals\" target=\"_blank\">Tenet Healthcare +14% after beat, Humana and HCA deals</a> (May 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271101\" data-linked=\"Tenet and Humana amend in-network access deal, effective date today; THC up 6%\" data-tweet=\"$THC $THC $HUM - Tenet and Humana amend in-network access deal, effective date today; THC up 6% https://seekingalpha.com/news/3271101-tenet-and-humana-amend-in-network-access-deal-effective-date-today-thc-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3271101-tenet-and-humana-amend-in-network-access-deal-effective-date-today-thc-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271099\" data-ts=\"1496343615\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271099-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Inc.'>ATOM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/TRT' title='Trio-Tech International'>TRT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/OIIM' title='O2Micro International Limited'>OIIM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/HPE' title='Hewlett Packard Enterprise'>HPE</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271099\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$SPI $JMU $PANW - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3271099-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3271099-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271097\" data-ts=\"1496343226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BEN\" target=\"_blank\">BEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271097-big-session-for-asset-managers-morgan-stanley-mulls-darwinian-moment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big session for asset managers; Morgan Stanley mulls &#39;Darwinian Moment&#39;</a></h4><ul><li>\"Intensifying secular changes\" will reshape the industry, <a href=\"http://www.barrons.com/articles/morgan-stanley-a-darwinian-moment-for-asset-managers-1496331957\" target=\"_blank\">says analyst Michael Cyprys</a>. He sees fee compression of 10-15% over the next three to five years offsetting asset growth, thus capping earnings power.</li><li>\"Darwinian?\" Indeed. The top three firms captured 35% of active equity inflows last year, up from 32% in 2015, and only 18% in 2010.</li><li>In the meantime, those firms way down the ladder in terms of performance, saw outflows.</li><li>Does that mean to sell the losers? Not necessarily, says Cyprus. Look for consolidation instead.</li><li>Perhaps that's on investors' minds today. Franklin Resources (<a href='https://seekingalpha.com/symbol/BEN' title='Franklin Resources Inc.'>BEN</a> <font color='green'>+2.2%</font>), Legg Mason (<a href='https://seekingalpha.com/symbol/LM' title='Legg Mason Inc.'>LM</a> <font color='green'>+2.4%</font>), Gamco (<a href='https://seekingalpha.com/symbol/GBL' title='Gamco Investors, Inc.'>GBL</a> <font color='green'>+1.7%</font>), Invesco (<a href='https://seekingalpha.com/symbol/IVZ' title='Invesco Ltd.'>IVZ</a> <font color='green'>+3.7%</font>), T. Rowe Price (<a href='https://seekingalpha.com/symbol/TROW' title='T. Rowe Price Group, Inc.'>TROW</a> <font color='green'>+1.9%</font>), Affiliated Managers (<a href='https://seekingalpha.com/symbol/AMG' title='Affiliated Managers Group'>AMG</a> <font color='green'>+4.9%</font>), Waddell &amp; Reed (<a href='https://seekingalpha.com/symbol/WDR' title='Waddell & Reed Financial Inc'>WDR</a> <font color='green'>+3.7%</font>), Artisan Partners (<a href='https://seekingalpha.com/symbol/APAM' title='Artisan Partners Asset Management'>APAM</a> <font color='green'>+3%</font>), Janus Henderson (<a href='https://seekingalpha.com/symbol/JHG' title='Janus Henderson Group plc'>JHG</a> <font color='green'>+5.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271097\" data-linked=\"Big session for asset managers; Morgan Stanley mulls &#39;Darwinian Moment&#39;\" data-tweet=\"$BEN $BEN $LM - Big session for asset managers; Morgan Stanley mulls &#39;Darwinian Moment&#39; https://seekingalpha.com/news/3271097-big-session-for-asset-managers-morgan-stanley-mulls-darwinian-moment?source=tweet\" data-url=\"https://seekingalpha.com/news/3271097-big-session-for-asset-managers-morgan-stanley-mulls-darwinian-moment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271096\" data-ts=\"1496343211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEL\" target=\"_blank\">CEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271096-cellcom-sets-debenture-placement-deferred-loan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellcom sets debenture placement, deferred loan</a></h4><ul>   <li>Cellcom Israel (<a href=\"http://seekingalpha.com/symbol/CEL\" target=\"_blank\">CEL</a> <font color='green'>+2.2%</font>) has announced a <a href=\"https://seekingalpha.com/pr/16849044-cellcom-israel-announces-private-debenture-placement-israel-closing-set-july-2018-cellcom\" target=\"_blank\">private debenture placement</a> along with a deferred loan agreement.</li>    <li>Institutional investors will purchase about 220M shekels (about $62M) in additional series K debentures on July 1, 2018. The price for each 1-shekel principal was set at 1.011 shekels, with an interest rate of 3.55%.</li>    <li>Meanwhile, the company has obtained an agreement for a loan of 150M shekels in March 2019, with annual fixed interest at 4%. Terms and obligations are similar to those in an August 2015 loan agreement from the same lender, Cellcom says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271096\" data-linked=\"Cellcom sets debenture placement, deferred loan\" data-tweet=\"$CEL - Cellcom sets debenture placement, deferred loan https://seekingalpha.com/news/3271096-cellcom-sets-debenture-placement-deferred-loan?source=tweet\" data-url=\"https://seekingalpha.com/news/3271096-cellcom-sets-debenture-placement-deferred-loan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271094\" data-ts=\"1496342482\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLR\" target=\"_blank\">FLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271094-fluor-upgraded-to-buy-da-davidson-bookings-catalysts-seen\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fluor upgraded to Buy at DA Davidson as bookings catalysts seen</a></h4><ul>     <li>Fluor (<a href='https://seekingalpha.com/symbol/FLR' title='Fluor Corporation'>FLR</a> <font color='green'>+2.7%</font>)&nbsp;is <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/06/9550195/there-is-now-opportunity-in-fluor-da-davidson-upgrades-t\" target=\"_blank\">upgraded to Buy</a> from Neutral with a $55 price target at DA Davidson, which notes that soft Q1 earnings and guidance and investor angst around Pres. Trump's infrastructure plans have sent shares 23% lower since breaching 52-week highs in mid-February.</li>     <li>Davidson says revived metal commodity prices continue to reignite interest in brownfield mining projects, where FLR is among the best-positioned companies globally with multiple front-end engineering contract awards over the past year, with the potential for larger awards as soon as H2 2017.</li>     <li>The firm anticipates investor flight toward stocks such as FLR with &ldquo;historical records of success and participation in key growth markets, clear financial liquidity to support internal/external growth objectives, and even greater entry 'price sensitivity'.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271094\" data-linked=\"Fluor upgraded to Buy at DA Davidson as bookings catalysts seen\" data-tweet=\"$FLR - Fluor upgraded to Buy at DA Davidson as bookings catalysts seen https://seekingalpha.com/news/3271094-fluor-upgraded-to-buy-da-davidson-bookings-catalysts-seen?source=tweet\" data-url=\"https://seekingalpha.com/news/3271094-fluor-upgraded-to-buy-da-davidson-bookings-catalysts-seen\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271093\" data-ts=\"1496341954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271093-wells-fargo-centurylinks-ceo-succession-positive-development\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo: CenturyLink&#39;s CEO succession a positive development</a></h4><ul>   <li>CenturyLink's (<a href=\"http://seekingalpha.com/symbol/CTL\" target=\"_blank\">CTL</a> <font color='green'>+6%</font>) move to set up Level 3 (<a href=\"http://seekingalpha.com/symbol/LVLT\" target=\"_blank\">LVLT</a> <font color='green'>+3.9%</font>) chief Jeff Storey as its <a href=\"https://seekingalpha.com/news/3270993-level-3s-storey-succeed-post-centurylink-ceo\" target=\"_blank\">CEO-in-waiting</a> is a \"significant positive\" for the soon-to-be-merged companies, Wells Fargo notes.</li>    <li>An activist investor pushed the plan, says analyst Jennifer Fritzsche, and that activist spoke for a number of investors pleased with Storey's tenure at Level 3: a significant turnaround, especially in North America. The company has beaten or matched EPS expectations for nine of the past 11 quarters.</li>    <li>Fritzsche and team rate both stocks Market Perform.</li>    <li>Level 3 hit an all-time high of $62.07 today.</li>    <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271093\" data-linked=\"Wells Fargo: CenturyLink&#39;s CEO succession a positive development\" data-tweet=\"$CTL $CTL $LVLT - Wells Fargo: CenturyLink&#39;s CEO succession a positive development https://seekingalpha.com/news/3271093-wells-fargo-centurylinks-ceo-succession-positive-development?source=tweet\" data-url=\"https://seekingalpha.com/news/3271093-wells-fargo-centurylinks-ceo-succession-positive-development\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271087\" data-ts=\"1496340232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271087-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/BRS' title='Bristow Group Inc.'>BRS</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/HOS' title='Hornbeck Offshore Services, Inc.'>HOS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271087\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$AKG $LLEX $LTBR - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3271087-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3271087-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:03 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271080\" data-ts=\"1496339606\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALDR\" target=\"_blank\">ALDR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271080-alder-biopharma-climbs-on-teva-migraine-treatment-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alder Biopharma climbs on Teva migraine treatment results</a></h4><ul><li>Positive results from the Phase 3 trial for Teva's&nbsp;fremanezumab bode well for all CGRP treatments says Wells Fargo's&nbsp;Jim Birchenough, and future data from Alder's (<a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a> <font color='green'>+6.5%</font>)&nbsp;eptinezumab should be equally strong.</li><li>Bloomberg&nbsp;Intelligence&rsquo;s Asthika Goonewardene agrees, and notes&nbsp;eptinezumab is the only IV option.</li><li>Source: Bloomberg's&nbsp;Bailey Lipschultz</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270722-tevas-fremanezumab-successful-late-stage-migraine-study-u-s-marketing-application-expected\" target=\"_blank\">Teva's fremanezumab successful in late-stage migraine study; U.S. marketing application expected this year; shares up 1%</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271080\" data-linked=\"Alder Biopharma climbs on Teva migraine treatment results\" data-tweet=\"$ALDR - Alder Biopharma climbs on Teva migraine treatment results https://seekingalpha.com/news/3271080-alder-biopharma-climbs-on-teva-migraine-treatment-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3271080-alder-biopharma-climbs-on-teva-migraine-treatment-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271069\" data-ts=\"1496336762\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271069-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/ONDK' title='OnDeck Capital'>ONDK</a> <font color='green'>+13%</font>. WAC <font color='green'>+9%</font>.RAS <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/OCN' title='Ocwen Financial Corporation'>OCN</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francés S.A.  ADR'>BFR</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/EQS' title='Equus Total Return'>EQS</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271069\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$ONDK $DHCP $RASF - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3271069-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3271069-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271062\" data-ts=\"1496336323\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NRG\" target=\"_blank\">NRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271062-nrg-energy-upgraded-to-buy-ubs-genon-settlement-pjm-add-clarity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NRG Energy upgraded to Buy at UBS as GenOn settlement, PJM add clarity</a></h4><ul><li>NRG&nbsp;Energy (<a href='https://seekingalpha.com/symbol/NRG' title='NRG Energy, Inc.'>NRG</a> <font color='green'>+3.2%</font>) pops more than 3% after UBS <a href=\"https://www.streetinsider.com/Analyst+EPS+Change/UPDATE%3A+UBS+Upgrades+NRG+Energy+%28NRG%29+to+Buy/12966122.html\" target=\"_blank\">upgrades shares to Buy</a> from Neutral and raises its price target to $20 from $19, saying the <a href=\"https://seekingalpha.com/news/3269320-nrg-energy-genon-bondholders-agree-restructuring\" target=\"_blank\">GenOn  settlement</a> and latest PJM auction add clarity while the  cost cutting thesis remains intact and the major near-term catalyst for  the stock.</li><li>While the deadline for the cost review is set for Aug. 14, UBS expects more details to come out sooner and could well see management update  2017 guidance in the coming weeks given the added clarity provided by  the GenOn settlement.</li><li>The firm continues to assume $140M of cost cuts  in its base case valuation and sees  further savings potential within the retail and renewable segments.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271062\" data-linked=\"NRG Energy upgraded to Buy at UBS as GenOn settlement, PJM add clarity\" data-tweet=\"$NRG - NRG Energy upgraded to Buy at UBS as GenOn settlement, PJM add clarity https://seekingalpha.com/news/3271062-nrg-energy-upgraded-to-buy-ubs-genon-settlement-pjm-add-clarity?source=tweet\" data-url=\"https://seekingalpha.com/news/3271062-nrg-energy-upgraded-to-buy-ubs-genon-settlement-pjm-add-clarity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271059\" data-ts=\"1496335618\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271059-deere-hits-all-time-high-analysts-cheer-largest-ever-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere hits all-time high as analysts cheer its largest-ever deal</a></h4><ul>     <li>Deere (<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='green'>+2.1%</font>) jumps to all-time highs in reaction to its largest-ever deal, the  planned <a href=\"https://seekingalpha.com/news/3270915-deere-buy-wirtgen-group-4_6b\" target=\"_blank\">$4.89B purchase</a> of road construction equipment maker Wirtgen Group, which analysts say will  help it lower its exposure to the agriculture equipment  business.</li>     <li>Jefferies says the deal <a href=\"http://www.barrons.com/articles/deere-you-like-it-you-really-like-it-1496329983\" target=\"_blank\">makes strategic and financial sense</a> for DE, increasing the company's exposure to global infrastructure markets; it notes that the deal is accretive and DE's &euro;100 mln in synergy target looks doable over five years.</li>     <li>Baird finds the deal attractive in strategic fit and purchase price, and says DE should be able to expand Wirtgen&rsquo;s U.S. reach while likely benefiting from Wirtgen&rsquo;s non-U.S. footprint.</li>     <li>Stifel says the deal appears reasonably priced, and estimates Wirtgen could provide EPS accretion up to $1 in 2018 even without aggressively incorporating synergies into its forecast</li>     <li>Source:&nbsp;Bloomberg First Word</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271059\" data-linked=\"Deere hits all-time high as analysts cheer its largest-ever deal\" data-tweet=\"$DE - Deere hits all-time high as analysts cheer its largest-ever deal https://seekingalpha.com/news/3271059-deere-hits-all-time-high-analysts-cheer-largest-ever-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3271059-deere-hits-all-time-high-analysts-cheer-largest-ever-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271055\" data-ts=\"1496335351\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271055-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color='green'>+36%</font>. <a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a> <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/SHLO' title='Shiloh Industries, Inc.'>SHLO</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/KMDA' title='Kamada Ltd'>KMDA</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/JMU' title='JMU Limited'>JMU</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/LLEX' title='Lilis Energy, Inc.'>LLEX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/XBIT' title='Xbiotech'>XBIT</a> <font color='green'>+16%</font>.</li><li><b>Losers:&nbsp;</b><a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/TANH' title='Tantech Holdings'>TANH</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ATOM' title='Atomera Inc.'>ATOM</a> <font color='red'>-12%</font>. NEOT <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/TRT' title='Trio-Tech International'>TRT</a> <font color='red'>-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271055\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SPI $NERV $AKG - Midday Gainers / Losers https://seekingalpha.com/news/3271055-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3271055-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271049\" data-ts=\"1496334446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271049-ge-selloff-presents-buying-opportunity-credit-suisse-says\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE selloff presents buying opportunity, Credit Suisse says</a></h4><ul>     <li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+1.4%</font>) shares have performed miserably this year, but Credit Suisse thinks <a href=\"http://247wallst.com/industrials/2017/06/01/why-credit-suisse-sees-ges-sell-off-as-a-big-opportunity/\" target=\"_blank\">bearish sentiment now is overstated</a>, and the risk/reward is starting to \"look more interesting.\"</li>     <li>In retaining its Outperform rating on the stock, Credit Suisse says GE \"is not a 'broken company,' although it may be somewhat misunderstood,\" thus the current share price presents an attractive entry point.</li>     <li>\"GE&rsquo;s organic growth profile seems under-appreciated by investors,\" the firm writes, and while acknowledging that equipment orders were weak over the past 18 months, \"the company&rsquo;s long-cycle nature means that it will naturally see a turn in such factors later than most industrial companies, who have shorter-cycle business models.\"</li>     <li>Credit Suisse says short-cycle trends have improved over the past nine months, and it expects GE&rsquo;s orders to improve over the next nine months.</li>     <li>The firm also thinks <a href=\"https://seekingalpha.com/news/3270792-dividend-cut-coming-ge-deutsche-bank-analyst-says\" target=\"_blank\">dividend concerns</a> are overblown; GE's industrial free cash flow is expected to reach ~$7.5B in 2017 vs. a ~$8B dividend payout, but additional cash flows should accrue from GE Capital and from the Baker Hughes acquisition, and a falling share count means the dividend cash payout likely will shrink even as dividend per share rises.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271049\" data-linked=\"GE selloff presents buying opportunity, Credit Suisse says\" data-tweet=\"$GE - GE selloff presents buying opportunity, Credit Suisse says https://seekingalpha.com/news/3271049-ge-selloff-presents-buying-opportunity-credit-suisse-says?source=tweet\" data-url=\"https://seekingalpha.com/news/3271049-ge-selloff-presents-buying-opportunity-credit-suisse-says\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>41&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271046\" data-ts=\"1496333665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271046-sinclair-broadcast-annual-meeting-board-returns-proposals-approved\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair Broadcast annual meeting: Board returns, proposals approved</a></h4><ul>   <li>At its drama-free annual meeting, Sinclair Broadcast Group (<a href=\"http://seekingalpha.com/symbol/SBGI\" target=\"_blank\">SBGI</a> <font color='green'>+2%</font>) <a href=\"https://seekingalpha.com/pr/16850093-sinclair-re-elects-board-ratifies-approves-proposals\" target=\"_blank\">re-elected its board</a> and ratified other pending proposals.</li>    <li>The board's eight members, including Executive Chairman David Smith, all were returned to their seats.</li>    <li>In addition, shareholders approved: PricewaterhouseCoopers as Sinclair's accountant; a nonbinding advisory vote on executive compensation; a triennial advisory vote for executive compensation; and the company's Executive Performance Formula and Incentive Plan.</li>    <li>With a <a href=\"https://seekingalpha.com/news/3264552-sinclair-broadcast-announces-3_9b-deal-tribune-media\" target=\"_blank\">$3.9B acquisition of Tribune Media</a> (<a href=\"http://seekingalpha.com/symbol/TRCO\" target=\"_blank\">TRCO</a> <font color='green'>+0.6%</font>) ahead, Sinclair is set to own, operate and/or provide service to 233 TV stations in 108 markets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271046\" data-linked=\"Sinclair Broadcast annual meeting: Board returns, proposals approved\" data-tweet=\"$SBGI $SBGI $TRCO - Sinclair Broadcast annual meeting: Board returns, proposals approved https://seekingalpha.com/news/3271046-sinclair-broadcast-annual-meeting-board-returns-proposals-approved?source=tweet\" data-url=\"https://seekingalpha.com/news/3271046-sinclair-broadcast-annual-meeting-board-returns-proposals-approved\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271045\" data-ts=\"1496333645\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZYME\" target=\"_blank\">ZYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271045-zymeworks-sells-off-after-flurry-of-sell-side-upgrades-down-11-today\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zymeworks sells off after flurry of sell-side upgrades; down 11% today</a></h4><ul><li>Investors who naively followed recent bullish sell-side ratings on Zymeworks (<a href='https://seekingalpha.com/symbol/ZYME' title='Zymeworks'>ZYME</a> <font color='red'>-11.4%</font>) have been bloodied as shares have slumped&nbsp;<font color='red'>20%</font>.</li><li>On May 23, four shops issued Buy ratings with price targets of $18 and $20 and shares started their descent two days later. Before then, the stock was range-bound between $13.00 and $13.50.</li><li>The company's lead product candidate is Phase 1-stage ZW25, a bispecific antibody for the potential treatment of breast, gastric and ovarian cancer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271045\" data-linked=\"Zymeworks sells off after flurry of sell-side upgrades; down 11% today\" data-tweet=\"$ZYME - Zymeworks sells off after flurry of sell-side upgrades; down 11% today https://seekingalpha.com/news/3271045-zymeworks-sells-off-after-flurry-of-sell-side-upgrades-down-11-today?source=tweet\" data-url=\"https://seekingalpha.com/news/3271045-zymeworks-sells-off-after-flurry-of-sell-side-upgrades-down-11-today\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271042\" data-ts=\"1496332834\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271042-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/MOD' title='Modine Manufacturing Company'>MOD</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CYRX' title='CryoPort, Inc.'>CYRX</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/GT' title='Goodyear Tire & Rubber Co.'>GT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SEED' title='Origin Agritech Limited'>SEED</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271042\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$KODK $MOD $CYRX - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3271042-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3271042-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271038\" data-ts=\"1496332505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRO\" target=\"_blank\">TSRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271038-tesaro-worth-240-share-suntrust\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TESARO worth $240/share - SunTrust</a></h4><ul><li>SunTrust's Peter Lawson <a href=\"https://www.streetinsider.com/Analyst+Comments/TESARO+%28TSRO%29+Worth+~%24240Share+in+a+Take-Out+-+SunTrust/12966888.html\" target=\"_blank\">says </a>TESARO (<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a> <font color='green'>+1%</font>), once again abuzz with takeout chatter, should fetch $240 (59% upside) a share. A key upcoming event is the release of late-stage data (ARIEL 3 study) on Clovis Oncology's Rubraca (rucaparib), a competitive PARP inhibitor to ZEJULA (niraparib), at the end of the month. The results should \"clarify the competitive landscape\" for potential acquirers.</li><li>According to a recent report by the WSJ, the level of interest in a takeover has been a bit soft after the company reached out to prospective buyers about a possible transaction.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270821-tesaro-exploring-sale-shares-4-percent-hours\" target=\"_blank\">TESARO exploring sale; shares up 4% after hours</a> (May 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271038\" data-linked=\"TESARO worth $240/share - SunTrust\" data-tweet=\"$TSRO - TESARO worth $240/share - SunTrust https://seekingalpha.com/news/3271038-tesaro-worth-240-share-suntrust?source=tweet\" data-url=\"https://seekingalpha.com/news/3271038-tesaro-worth-240-share-suntrust\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271037\" data-ts=\"1496332377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDQ\" target=\"_blank\">NVDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271037-novadaq-up-nearly-5-on-report-of-possible-aetna-coverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novadaq up nearly 5% on report of possible Aetna coverage</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls/status/870304534987407360\" target=\"_blank\">via Notable Calls</a></li><li>In what would be a big win for Navadaq Technologies (<a href='https://seekingalpha.com/symbol/NVDQ' title='Novadaq Technologies Inc.'>NVDQ</a> <font color='green'>+4.6%</font>), Stifel is saying Aetna may now cover DermACELL</li><li>Previously: <a href=\"https://seekingalpha.com/news/3245009-cigna-cover-dermacell-dermal-matrix-exclusive-distributor-novadaq-9-percent-hours\" target=\"_blank\">Cigna to cover Dermacell dermal matrix; exclusive distributor Novadaq up 9% after hours</a> (Feb. 21)</li></ul><div class=\"tiny-share-widget\" data-id=\"3271037\" data-linked=\"Novadaq up nearly 5% on report of possible Aetna coverage\" data-tweet=\"$NVDQ - Novadaq up nearly 5% on report of possible Aetna coverage https://seekingalpha.com/news/3271037-novadaq-up-nearly-5-on-report-of-possible-aetna-coverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3271037-novadaq-up-nearly-5-on-report-of-possible-aetna-coverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271039\" data-ts=\"1496332118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKG\" target=\"_blank\">AKG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271039-asanko-gold-bounces-back-from-muddy-waters-short-analysts-defend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Asanko Gold bounces back from Muddy Waters short as analysts defend</a></h4><ul>     <li>Asanko Gold (<a href='https://seekingalpha.com/symbol/AKG' title='Asanko Gold Inc.'>AKG</a> <font color='green'>+27.9%</font>) rebounds from <a href=\"https://seekingalpha.com/news/3270733-asanko-gold-minus-15-percent-muddy-waters-says-short\" target=\"_blank\">yesterday's 31% plunge</a> that followed news that Muddy Waters was shorting the miner's shares,</li>     <li>AKG <a href=\"https://seekingalpha.com/pr/16848582-asanko-gold-release-expanded-mine-feasibility-report-refutes-muddy-waters-short-report\" target=\"_blank\">responded</a> late yesterday with a promise to release an expanded feasibility study on its mine plans on Monday, which it said would \"provide a complete rebuttal\" to the Muddy Waters claims.</li>     <li>Analysts are <a href=\"http://www.nasdaq.com/article/asanko-gold-rebounds-despite-muddy-waters-stock-short-20170601-01047\" target=\"_blank\">out in support</a> of AKG, with many saying the company already has addressed a key issue of remediation work required for the damaged western wall of its mine pit; Muddy Waters says a $115M pit wall pushback is needed to repair the damage, but AKG disagrees.</li>     <li>Scotiabank says it \"continues to favor the merits of Asanko's key projects and team,\" but the \"mud slinging\" makes the company's update on Monday increasingly important.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271039\" data-linked=\"Asanko Gold bounces back from Muddy Waters short as analysts defend\" data-tweet=\"$AKG - Asanko Gold bounces back from Muddy Waters short as analysts defend https://seekingalpha.com/news/3271039-asanko-gold-bounces-back-from-muddy-waters-short-analysts-defend?source=tweet\" data-url=\"https://seekingalpha.com/news/3271039-asanko-gold-bounces-back-from-muddy-waters-short-analysts-defend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271034\" data-ts=\"1496331695\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271034-gs-reiterates-bullish-call-on-valeant-debt-shares-ahead-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GS reiterates bullish call on Valeant debt; shares ahead 4%</a></h4><ul><li>Goldman Sachs Credit Research analyst Shubhomoy Mukherjee <a href=\"https://www.streetinsider.com/Analyst+Comments/Valeant+Pharma+%28VRX%29+Credit+Reiterated+Outperform+At+Goldman+Sachs%2C+Xifaxan+Trends+Are+%22Underwhelming%22/12966084.html\" target=\"_blank\">says </a>Valeant Pharmaceuticals' (VRX <font color='green'>+4.3%</font>) credit story remains optimistic because it should be able to progressively pay down debt via cash on hand, free cash flow, asset sales and available (but limited) secured debt capacity while likely to refinance maturities until fiscal 2020.</li><li>Debt payments through 2020 total a bit over $7B while cash from operations, cash on hand and asset sales should tally about the same amount or slightly more.</li><li>He adds that he is \"cautious\" about the company's 2017 guidance citing soft Xifaxan prescription trends (down 2% yoy) but the dermatology franchise remains stable.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271034\" data-linked=\"GS reiterates bullish call on Valeant debt; shares ahead 4%\" data-tweet=\"$BHC - GS reiterates bullish call on Valeant debt; shares ahead 4% https://seekingalpha.com/news/3271034-gs-reiterates-bullish-call-on-valeant-debt-shares-ahead-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3271034-gs-reiterates-bullish-call-on-valeant-debt-shares-ahead-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>80&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271033\" data-ts=\"1496331469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TI\" target=\"_blank\">TI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271033-reuters-vivendi-ceo-named-chairman-telecom-italia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Vivendi CEO named chairman at Telecom Italia</a></h4><ul>   <li>With a tussle for control of Telecom Italia (<a href=\"http://seekingalpha.com/symbol/TI\" target=\"_blank\">TI</a> <font color='red'>-0.5%</font>) <a href=\"https://seekingalpha.com/news/3270516-vivendi-gets-ec-antitrust-ok-control-telecom-italia\" target=\"_blank\">largely coming to an end</a>, the company has appointed Vivendi (<a href=\"http://seekingalpha.com/symbol/VIVHY\" target=\"_blank\">VIVHY</a> <font color='green'>+1.7%</font>) CEO Arnaud de Puyfontaine <a href=\"http://www.reuters.com/article/us-telecomitalia-vivendi-chairman-idUSKBN18S5LC\" target=\"_blank\">as its chairman</a>, Reuters reports.</li>    <li>Vivendi got conditional approval from the EU's antitrust regulators to take control of Telecom Italia, in which it's been building a 24% stake, against a backdrop of Italian resistance to heavy foreign control of companies it considers national assets.</li>    <li>De Puyfontaine replaces Giuseppe Recchi in the chairman's role; Recchi reportedly becomes deputy chairman.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271033\" data-linked=\"Reuters: Vivendi CEO named chairman at Telecom Italia\" data-tweet=\"$TI $TI $VIVHY - Reuters: Vivendi CEO named chairman at Telecom Italia https://seekingalpha.com/news/3271033-reuters-vivendi-ceo-named-chairman-telecom-italia?source=tweet\" data-url=\"https://seekingalpha.com/news/3271033-reuters-vivendi-ceo-named-chairman-telecom-italia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271032\" data-ts=\"1496331458\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271032-lululemon-earnings-on-tap\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon earnings on tap</a></h4><ul> <li>Lululemon (<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a> <font color='green'>+0.5%</font>) reports FQ1 results after the market closes today. Consensus estimates are for revenue of $514M, comparable sales growth of -1.9% and EPS of $0.28.</li> <li>Stifel Nicolaus thinks the company will meet estimates due to some recent improvement in North America, while noting that the real focus from investors will be on the back-half guidance on comparable sales growth.</li> <li>Bloomberg data suggests a double-digit move up or down for shares following the report. Lululemon is down roughly 25% since the last time it spilled numbers.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3271032\" data-linked=\"Lululemon earnings on tap\" data-tweet=\"$LULU - Lululemon earnings on tap https://seekingalpha.com/news/3271032-lululemon-earnings-on-tap?source=tweet\" data-url=\"https://seekingalpha.com/news/3271032-lululemon-earnings-on-tap\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271030\" data-ts=\"1496329786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHTR\" target=\"_blank\">CHTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271030-report-charter-rebuffs-100b-plus-verizon-buyout-offer-sirius-xm-eyed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Charter rebuffs $100B-plus Verizon buyout offer; Sirius XM eyed</a></h4><ul>     <li>Charter Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) has rebuffed a <a href=\"http://nypost.com/2017/05/31/cable-giant-charter-snubbed-a-buyout-bid-from-verizon/\" target=\"_blank\">buyout offer well over $100B</a> from Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color='red'>-0.6%</font>) as too low, the <i>New York Post</i> reports.</li>     <li>Three sources told the paper that Verizon -- linked to deal chatter around several companies in recent months -- made a proposal to acquire Charter for $350-$400/share. Charter's <font color='red'>down -0.7%</font> to $343.20 currently.</li>   <li>Several analysts have said Verizon needs a transformative acquisition, likely including fiber-optic networks, to make a splash as it pursues 5G wireless plans in a hotly competitive sector.</li>      <li>The sources also said Verizon expressed interest in buying Sirius XM (<a href=\"http://seekingalpha.com/symbol/SIRI\" target=\"_blank\">SIRI</a> <font color='green'>+3.8%</font>), but that didn't translate into a bid.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271030\" data-linked=\"Report: Charter rebuffs $100B-plus Verizon buyout offer; Sirius XM eyed\" data-tweet=\"$CHTR $CHTR $VZ - Report: Charter rebuffs $100B-plus Verizon buyout offer; Sirius XM eyed https://seekingalpha.com/news/3271030-report-charter-rebuffs-100b-plus-verizon-buyout-offer-sirius-xm-eyed?source=tweet\" data-url=\"https://seekingalpha.com/news/3271030-report-charter-rebuffs-100b-plus-verizon-buyout-offer-sirius-xm-eyed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271027\" data-ts=\"1496329260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271027-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories:</a> Crude <strong>-6.4M</strong> barrels vs. -2.5M consensus, -4.4M last week.</li>     <li>Gasoline <strong>-2.9M</strong> barrels vs. -1.1M consensus, -0.8M last week.</li>     <li>Distillates +<strong>0.4M </strong>vs. -0.8M consensus, -0.5M last week.</li>     <li>Futures&nbsp;<font color='green'>+0.66%</font>&nbsp;to $48.64.</li>     <li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3271027\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3271027-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3271027-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>71&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271009\" data-ts=\"1496329255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271009-healthcare-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/KMDA' title='Kamada Ltd'>KMDA</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/KDMN' title='Kadmon Holdings'>KDMN</a> <font color='green'>+12%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NSTG' title='NanoString Technologies'>NSTG</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/PTGX' title='Protagonist Therapeutics'>PTGX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271009\" data-linked=\"Healthcare Gainers / Losers as of 11:00 am\" data-tweet=\"$NERV $SNCA $KMDA - Healthcare Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3271009-healthcare-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3271009-healthcare-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271022\" data-ts=\"1496328682\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUR\" target=\"_blank\">CUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271022-neuralstem-up-19-on-prospects-of-nsiminus-189-for-mdd\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neuralstem up 19% on prospects of NSI-189 for MDD</a></h4><ul><li>Thinly traded nano cap Neuralstem (<a href='https://seekingalpha.com/symbol/CUR' title='Neuralstem, Inc.'>CUR</a> <font color='green'>+18.8%</font>) is up in early trading on a 50% spike in volume. Yesterday, the company released a <a href=\"https://seekingalpha.com/article/4077627-neuralstem-cur-investor-presentation-slideshow\" target=\"_blank\">corporate presentation</a> on lead product candidate NSI-189 that showed its potential effect in treating major depressive disorder &#40;MDD&#41;. Phase 1b results showed a large effect across multiple metrics. Phase 2 data should be available next quarter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271022\" data-linked=\"Neuralstem up 19% on prospects of NSI-189 for MDD\" data-tweet=\"$CUR $SNCA - Neuralstem up 19% on prospects of NSI-189 for MDD https://seekingalpha.com/news/3271022-neuralstem-up-19-on-prospects-of-nsiminus-189-for-mdd?source=tweet\" data-url=\"https://seekingalpha.com/news/3271022-neuralstem-up-19-on-prospects-of-nsiminus-189-for-mdd\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271020\" data-ts=\"1496328453\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DG\" target=\"_blank\">DG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271020-major-upgrade-from-gordon-haskett-on-dollar-general\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Major upgrade from Gordon Haskett on Dollar General</a></h4><ul> <li>Gordon Haskett's Chuck Grom upgrades Dollar General (<a href='https://seekingalpha.com/symbol/DG' title='Dollar General Corporation'>DG</a> <font color='green'>+3.6%</font>) to Accumulate from Reduce in a two-notch move after taking in the retailer's Q1 report.</li> <li>The analyst notes that Dollar General's new store productivity improved to 82.8% in the quarter, compared to a trailing eight quarter average of 75.2%. He also points to the outperformance in the apparel and consumables categories.</li> <li>\"We are raising our estimates to take into consideration the 1Q beat, greater than expected buybacks, accretion from 322 acquired stores, and a generally more favorable outlook.  Accordingly, we are raising our FY17 EPS estimate from $4.45 to $4.55, and our FY18 EPS estimate from $4.80 to $5.00.  Finally, we are raising our Price Target from $67 to $84, which is based on 16.7x our FY18 estimate,\" write Grom.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3270897-dollar-general-beats-0_03-beats-revenue\" target=\"_blank\">Dollar General beats by $0.03, beats on revenue</a> (June 1)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3271020\" data-linked=\"Major upgrade from Gordon Haskett on Dollar General\" data-tweet=\"$DG - Major upgrade from Gordon Haskett on Dollar General https://seekingalpha.com/news/3271020-major-upgrade-from-gordon-haskett-on-dollar-general?source=tweet\" data-url=\"https://seekingalpha.com/news/3271020-major-upgrade-from-gordon-haskett-on-dollar-general\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271017\" data-ts=\"1496327449\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271017-eia-natural-gas-inventory\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Natural Gas Inventory</a></h4><ul>     <li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+85&nbsp;</strong><strong>Bcf</strong> vs. +78 Bcf consensus, +75 Bcf last week.</li><li>Futures&nbsp;<font color='red'>-0.13%</font>&nbsp;to $3.067.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>,<a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3271017\" data-linked=\"EIA Natural Gas Inventory\" data-tweet=\"$UNG $DGAZ $UGAZ - EIA Natural Gas Inventory https://seekingalpha.com/news/3271017-eia-natural-gas-inventory?source=tweet\" data-url=\"https://seekingalpha.com/news/3271017-eia-natural-gas-inventory\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271003\" data-ts=\"1496326191\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SESN\" target=\"_blank\">SESN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271003-eleven-bios-late-stage-study-of-vicinium-in-bladder-cancer-to-continue-planned-shares-up-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eleven Bio&#39;s late-stage study of Vicinium in bladder cancer to continue as planned; shares up 10%</a></h4><ul><li>Nano cap Eleven Biotherapeutics (EBIO <font color='green'>+10.2%</font>) perks up on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16849282-eleven-biotherapeutics-announces-data-safety-monitoring-board-dsmb-recommendation-continue\" target=\"_blank\">announcement </a>that its pivotal Phase 3 clinical trial assessing Vicinium in non-muscle invasive bladder cancer has exceeded 50% enrollment and the trial will proceed was planned without modification as recommended by the independent Data and Safety Monitoring Board. The study should be fully enrolled in H2. Three-month data should be available in Q2 2018.</li><li><a href=\"http://www.elevenbio.com/pipeline/vicinium.html\" target=\"_blank\">Vicinium </a>is a recombinant fusion protein designed to specifically target and deliver an anti-cancer payload directly to tumor cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3271003\" data-linked=\"Eleven Bio&#39;s late-stage study of Vicinium in bladder cancer to continue as planned; shares up 10%\" data-tweet=\"$SESN - Eleven Bio&#39;s late-stage study of Vicinium in bladder cancer to continue as planned; shares up 10% https://seekingalpha.com/news/3271003-eleven-bios-late-stage-study-of-vicinium-in-bladder-cancer-to-continue-planned-shares-up-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3271003-eleven-bios-late-stage-study-of-vicinium-in-bladder-cancer-to-continue-planned-shares-up-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3271000\" data-ts=\"1496325565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BB\" target=\"_blank\">BB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3271000-blackberryplus-6_2-citron-ponders-whether-next-nvidia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BlackBerry +6.2% as Citron ponders whether it&#39;s the &#39;next Nvidia&#39;</a></h4><ul>   <li>BlackBerry (BBRY) is <font color='green'>up 6.2%</font> as Citron Research raises the question of whether the company is <a href=\"http://www.citronresearch.com/blackberry-next-nvidia/\" target=\"_blank\">the \"next Nvidia.\"</a></li>    <li>Nvidia raised its enterprise value manifold with only a doubling in revenues over the past couple of years, the firm's report notes, because the Street stopped seeing Nvidia as just a graphic chip company and looked past that to autonomous driving, AI and data centers.</li>    <li>Similarly, BlackBerry is out of phone handsets and focused on security software. \"When Wall Street shifts its frame of expectations toward the future, and gets over their legacy business, watch out.\"</li>    <li>Citron notes SA contributor <a href=\"https://seekingalpha.com/article/4074578-blackberry-verge-disruption?li_source=LI&amp;li_medium=liftigniter-widget\" target=\"_blank\">Paulo Santos' recent bear case</a> on the company (Google emerging as an automotive player pushing BlackBerry to fringes), saying a similar argument applied to Mobileye \"before it got acquired for $15B.\" BlackBerry can be an acquisition target for \"countless\" suitors, Citron's report says.</li>    <li>It set a 24-month price target of $20, implying 78% upside, or a buyout at a sizable premium.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3271000\" data-linked=\"BlackBerry +6.2% as Citron ponders whether it&#39;s the &#39;next Nvidia&#39;\" data-tweet=\"$BB - BlackBerry +6.2% as Citron ponders whether it&#39;s the &#39;next Nvidia&#39; https://seekingalpha.com/news/3271000-blackberryplus-6_2-citron-ponders-whether-next-nvidia?source=tweet\" data-url=\"https://seekingalpha.com/news/3271000-blackberryplus-6_2-citron-ponders-whether-next-nvidia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270993\" data-ts=\"1496324565\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTL\" target=\"_blank\">CTL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270993-level-3s-storey-to-succeed-post-centurylink-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Level 3&#39;s Storey to succeed Post as CenturyLink CEO</a></h4><ul>   <li>CenturyLink (<a href=\"http://seekingalpha.com/symbol/CTL\" target=\"_blank\">CTL</a> <font color='green'>+3.8%</font>) has set <a href=\"https://seekingalpha.com/pr/16849245-centurylink-announces-ceo-succession-plan\" target=\"_blank\">succession for its chief executive officer role</a>, making Level 3's (<a href=\"http://seekingalpha.com/symbol/LVLT\" target=\"_blank\">LVLT</a> <font color='green'>+2.5%</font>) Jeff Storey the heir apparent after the two companies merge.</li>    <li>Storey -- currently president and CEO at Level 3 -- will join the merged company as president and chief operating officer, with CenturyLink's Glen Post III remaining in the CEO job.</li>    <li>Storey will succeed Post as CEO of the merged company effective Jan. 1, 2019, at which time Post will become executive chairman.</li>    <li>Also, Vice Chairman Harvey Perry has been appointed chairman effective immediately, and W. Bruce Hanks made vice chairman.</li>    <li>After the acquisition closes (still expected by Sept. 30), Post's direct reports including Storey will be Stacey Goff as executive VP, general counsel and chief administrative officer; Sunit Patel, executive VP and CFO; and Scott Trezise, executive VP, human resources.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270993\" data-linked=\"Level 3&#39;s Storey to succeed Post as CenturyLink CEO\" data-tweet=\"$CTL $CTL $LVLT - Level 3&#39;s Storey to succeed Post as CenturyLink CEO https://seekingalpha.com/news/3270993-level-3s-storey-to-succeed-post-centurylink-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3270993-level-3s-storey-to-succeed-post-centurylink-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270990\" data-ts=\"1496324262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCO\" target=\"_blank\">TCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270990-taubman-centers-defeats-activist-bid-for-board-seats-shares-down-1_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Taubman Centers defeats activist bid for board seats; shares down 1.8%</a></h4><ul><li>Preliminary results <a href=\"https://seekingalpha.com/pr/16849566-taubman-announces-preliminary-results-annual-meeting-shareholders\" target=\"_blank\">indicate all of </a>Taubman's (<a href='https://seekingalpha.com/symbol/TCO' title='Taubman Centers, Inc.'>TCO</a> <font color='red'>-1.8%</font>) nominees have won election to the board - a defeat for activist Land &amp; Buildings. Included in those winning are Chairman and CEO Bobby Taubman and lead director Mike Ullman.</li><li>The company remains committed to declassifying the board no later than the 2018 annual meeting.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270990\" data-linked=\"Taubman Centers defeats activist bid for board seats; shares down 1.8%\" data-tweet=\"$TCO - Taubman Centers defeats activist bid for board seats; shares down 1.8% https://seekingalpha.com/news/3270990-taubman-centers-defeats-activist-bid-for-board-seats-shares-down-1_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3270990-taubman-centers-defeats-activist-bid-for-board-seats-shares-down-1_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270988\" data-ts=\"1496323871\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/F\" target=\"_blank\">F</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270988-f-series-and-suvs-lead-ford-to-solid-month-in-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">F-Series and SUVs lead Ford to solid month in the U.S.</a></h4><ul>     <li>Ford (NYSE:<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a>) turns in another solid month of sales in the U.S., led by strong demand for the F-Series (+13% Y/Y), Expedition (+14%) and Explorer (+21%).</li>   <li>Sales growth by brand: Ford +2.1% to 230,838 units, Lincoln +4.9% to 10,288 units.</li>     <li>Ford's average transaction price +5.0% Y/Y to $38,428 (per KBB), due largely to the shift in mix.</li>  <li>\"May marked a standout month for Ford brand SUVs, with a May record 74,910 SUVs sold,\" notes U.S. sales exec Mark LaNeve.</li> <li>Ford's inventory fell to 72 days supply, compared to 83 days at the end of April and 74 days a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3270984-ford-tops-may-u-s-sales-estimates\" target=\"_blank\">Ford tops May U.S. sales estimates</a> (June 1)</li><li>Shares of Ford are&nbsp;<font color='green'>up 1.26%</font>&nbsp;to $11.26.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270988\" data-linked=\"F-Series and SUVs lead Ford to solid month in the U.S.\" data-tweet=\"$F - F-Series and SUVs lead Ford to solid month in the U.S. https://seekingalpha.com/news/3270988-f-series-and-suvs-lead-ford-to-solid-month-in-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3270988-f-series-and-suvs-lead-ford-to-solid-month-in-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>47&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270986\" data-ts=\"1496323672\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLX\" target=\"_blank\">PLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270986-protalix-gets-fda-nod-to-expand-product-manufacturing-carmiel-site-shares-ahead-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Protalix gets FDA nod to expand product manufacturing at Carmiel site; shares ahead 6% premarket</a></h4><ul><li>Protalix BioTherapeutics (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLX' title='Protalix BioTherapeutics, Inc'>PLX</a>) perks up&nbsp;<font color='green'>6%&nbsp;</font>premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16849194-protalix-biotherapeutics-announces-fda-approval-operate-current-facility-multi-product\" target=\"_blank\">announcement</a> that the FDA has approved its conversion of its Carmiel, Israel manufacturing site to a multi-product facility, thereby being able to accommodate all of its current and expected commercial and clinical needs, including Fabry candidate PRX-102.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270986\" data-linked=\"Protalix gets FDA nod to expand product manufacturing at Carmiel site; shares ahead 6% premarket\" data-tweet=\"$PLX - Protalix gets FDA nod to expand product manufacturing at Carmiel site; shares ahead 6% premarket https://seekingalpha.com/news/3270986-protalix-gets-fda-nod-to-expand-product-manufacturing-carmiel-site-shares-ahead-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3270986-protalix-gets-fda-nod-to-expand-product-manufacturing-carmiel-site-shares-ahead-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270985\" data-ts=\"1496323252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270985-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a> <font color='green'>+56%</font>&nbsp;on entering into an <a href=\"https://seekingalpha.com/pr/16849199-spi-energy-co-ltd-announces-agreement-capital-stage-ag-sell-uk-solar-project\" target=\"_blank\">agreement</a> to sell the entire issued share capital of Todderstaffe Solar.</li>     <li><a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='green'>+17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3270906-mannkind-inks-afrezza-distribution-deal-brazil-shares-ahead-17-percent-premarket\" target=\"_blank\">agreement</a> of Afrezza distribution deal in Brazil.</li>     <li><a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a> <font color='green'>+13%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3270809-palo-alto-networks-beats-0_06-beats-revenue\" target=\"_blank\">earnings</a>.</li>     <li><a href='https://seekingalpha.com/symbol/NERV' title='Minerva Neurosciences'>NERV</a> <font color='green'>+12%</font>&nbsp;on amended agreement with Janssen Pharmaceutica NV.</li>     <li><a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a> <font color='green'>+11%</font>&nbsp; on Q2 <a href=\"https://seekingalpha.com/news/3270902-ciena-beats-0_16-beats-revenue\" target=\"_blank\">result</a>.</li>     <li>EBIO <font color='green'>+7%</font>&nbsp;on Phase 3 r<a href=\"https://seekingalpha.com/pr/16849282-eleven-biotherapeutics-announces-data-safety-monitoring-board-dsmb-recommendation-continue\" target=\"_blank\">egistration</a> trial of Vicinium.</li>     <li><a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a> <font color='green'>+6%</font>&nbsp;on Q1 <a href=\"https://seekingalpha.com/news/3270812-box-beats-0_01-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/GT' title='Goodyear Tire & Rubber Co.'>GT</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/PF' title='Pinnacle Foods'>PF</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270985\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$SPI $MNKD $PANW - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3270985-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3270985-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270982\" data-ts=\"1496322767\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270982-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a>&nbsp;<font color='red'>-22%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3270892-express-misses-0_05-misses-revenue\" target=\"_blank\">Q1 earnings</a> miss.</li><li><a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3270785-microbot-nabs-canadian-patent-protecting-self-cleaning-shunt-shares-ahead-27-percent\" target=\"_blank\">grabbing</a> Canadian patent protecting self-cleaning shunt.</li><li><a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='red'>-8%</font>.</li><li><a href='https://seekingalpha.com/symbol/SMTC' title='Semtech Corporation'>SMTC</a>&nbsp;<font color='red'>-5%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3270829-semtech-beats-0_03-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3270982\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$EXPR $MBOT $SBGL - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3270982-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3270982-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270979\" data-ts=\"1496322342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WHLR\" target=\"_blank\">WHLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270979-reeling-wheeler-real-estate-affirms-full-year-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reeling Wheeler Real Estate affirms full-year outlook</a></h4><ul><li>\"The Board of Directors believes that the recent decline in the trading prices of its securities is unwarranted based on the performance of the portfolio,\" <a href=\"https://seekingalpha.com/pr/16849400-wheeler-real-estate-investment-trust-inc-board-directors-reaffirms-full-year-2017-guidance\" target=\"_blank\">says the company</a>. Shares are&nbsp;<font color='red'>off 40%</font>&nbsp;over the last month.</li><li>Management and the board continue to work to cut costs and boost leasing. Q1 occupancy was 94.2%. Through Q1, 33 leases were renewed at a rent spread of 3.5%.</li><li>The company promises to pursue all avenues to boost shareholder value.</li><li>Full-year guidance of $1.48-$1.55 (we're assuming this is FFO per share) is affirmed.</li><li><a href='https://seekingalpha.com/symbol/WHLR' title='Wheeler Real Estate Investment Trust'>WHLR</a>&nbsp;<font color='green'>+1.9%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3270979\" data-linked=\"Reeling Wheeler Real Estate affirms full-year outlook\" data-tweet=\"$WHLR - Reeling Wheeler Real Estate affirms full-year outlook https://seekingalpha.com/news/3270979-reeling-wheeler-real-estate-affirms-full-year-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3270979-reeling-wheeler-real-estate-affirms-full-year-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270972\" data-ts=\"1496321883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270972-treasury-yields-move-higher-after-blowout-adp-jobs-number\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Treasury yields move higher after blowout ADP jobs number</a></h4><ul><li><a href=\"https://seekingalpha.com/news/3270950-u-s-economy-added-253k-jobs-may\" target=\"_blank\">The ADP reports </a>253K private-sector jobs added in May, up from 177K in April, and against expectations for just 170K.</li><li>May's 253K print is roughly inline with the average for the first three months of 2017.</li><li>The 10-year Treasury yield has moved up just shy of two basis points to 2.225%. <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-0.45%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+0.9%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3270972\" data-linked=\"Treasury yields move higher after blowout ADP jobs number\" data-tweet=\"$TLT $TBT - Treasury yields move higher after blowout ADP jobs number https://seekingalpha.com/news/3270972-treasury-yields-move-higher-after-blowout-adp-jobs-number?source=tweet\" data-url=\"https://seekingalpha.com/news/3270972-treasury-yields-move-higher-after-blowout-adp-jobs-number\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270968\" data-ts=\"1496321367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPMX\" target=\"_blank\">BPMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270968-biopharmx-acne-candidate-successful-in-mid-stage-study-shares-ahead-8-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioPharmX acne candidate successful in mid-stage study; shares ahead 8% premarket</a></h4><ul><li>Nano cap BioPharmX (NYSEMKT:<a href='https://seekingalpha.com/symbol/BPMX' title='BioPharmX Corporation'>BPMX</a>) is up&nbsp;<font color='green'>8%&nbsp;</font>premarket on higher-than-normal volume in response to its <a href=\"https://seekingalpha.com/pr/16849414-biopharmx-advances-bpxminus-01-2-percent-upon-achieving-statistical-significance-primary\" target=\"_blank\">announcement</a> of positive results from a Phase 2b clinical trial assessing the 2% formulation of BPX-01 for the treatment of acne vulgaris. The data showed treatment with BPX-01 reduced the number of inflammatory lesions by 59% compared to 44% for vehicle (placebo) at week 12, a statistically significant result. The were no serious drug-related adverse events observed.</li><li>The data will be presented today at the \"State of Acne\" symposium in NYC.</li><li><a href=\"http://www.biopharmx.com/products/#pipeline\" target=\"_blank\">BPX-01</a>&nbsp;is a fully solubilized, non-oily topical minocycline gel. The formulation delivers the antibiotic directly to the source of acne while avoiding systemic exposure.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270968\" data-linked=\"BioPharmX acne candidate successful in mid-stage study; shares ahead 8% premarket\" data-tweet=\"$BPMX - BioPharmX acne candidate successful in mid-stage study; shares ahead 8% premarket https://seekingalpha.com/news/3270968-biopharmx-acne-candidate-successful-in-mid-stage-study-shares-ahead-8-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3270968-biopharmx-acne-candidate-successful-in-mid-stage-study-shares-ahead-8-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270967\" data-ts=\"1496321350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270967-citi-positive-on-skechers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi positive on Skechers</a></h4><ul> <li>Citi <a href=\"http://www.cnbc.com/2017/06/01/early-movers-ppg-de-expr-dg-cien-klac-panw-more.html\" target=\"_blank\">upgrades</a> Skechers (NYSE:<a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a>) to a Buy rating after having the shoe seller locked in at Neutral.</li> <li>The investment firm thinks Skechers is taking market share from value-oriented peers and will benefit from a new product cycle.</li> <li>The price target on Skechers goes to $30.</li> <li>SKX <font color='green'>+3.80%</font> premarket to $26.49.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270967\" data-linked=\"Citi positive on Skechers\" data-tweet=\"$SKX - Citi positive on Skechers https://seekingalpha.com/news/3270967-citi-positive-on-skechers?source=tweet\" data-url=\"https://seekingalpha.com/news/3270967-citi-positive-on-skechers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270961\" data-ts=\"1496320349\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HL\" target=\"_blank\">HL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270961-judge-blocks-hecla-minings-montana-project-over-environmental-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Judge blocks Hecla Mining&#39;s Montana project over environmental concerns</a></h4><ul>     <li>Hecla Mining (NYSE:<a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a>) <font color='red'>-5.9%</font> premarket after a federal judge in Montana <a href=\"http://www.reuters.com/article/montana-mine-idUSL1N1IX2DI\" target=\"_blank\">blocks development</a> of the Montanore mine in the northwest part of the state, handing a victory to environmentalists who had argued the project could endanger grizzly bears and bull trout.</li>     <li>The judge cited the Endangered Species Act and other environmental laws in a pair of rulings late yesterday in effectively canceling the U.S. Forest Service permit issued last year for the proposed copper and silver mine.</li>     <li>HL says it is deciding on its next steps and does not rule out appealing the judge's ruling or applying for a new permit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270961\" data-linked=\"Judge blocks Hecla Mining&#39;s Montana project over environmental concerns\" data-tweet=\"$HL - Judge blocks Hecla Mining&#39;s Montana project over environmental concerns https://seekingalpha.com/news/3270961-judge-blocks-hecla-minings-montana-project-over-environmental-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3270961-judge-blocks-hecla-minings-montana-project-over-environmental-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270919\" data-ts=\"1496320314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIEN\" target=\"_blank\">CIEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270919-ciena-q1-beats-estimates-issues-strong-guidance-shares-up-over-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ciena Q1 beats estimates, issues strong guidance; shares up over 10%</a></h4><ul><li>Ciena Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/CIEN' title='Ciena Corporation'>CIEN</a>) Q2 report beat EPS and revenue estimates. Other key metrics include 45.7% gross margin, 12.5% operating margin, $234.6M in operating expenses, $993.3M cash and investments, and $72M cash flow from operations.</li><li>Segment sales: Networking Platforms: $571.5M (+81% Y/Y); Software and Software-Related Services: $37.7M (+5.4%); Global Services: $97.8M (+13.8%).</li><li>Q3 guidance includes $710M to $740M in revenue, compared to $723.04M consensus, and an operating expense of $235M.</li><li>Ciena shares are&nbsp;<font color='green'>up over 10%&nbsp;p</font>remarket.</li><li><a href=\"https://seekingalpha.com/pr/16849089-ciena-reports-fiscal-second-quarter-2017-financial-results\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3270902-ciena-beats-0_16-beats-revenue\" target=\"_blank\">Ciena beats by $0.16, beats on revenue</a> (June 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3270919\" data-linked=\"Ciena Q1 beats estimates, issues strong guidance; shares up over 10%\" data-tweet=\"$CIEN - Ciena Q1 beats estimates, issues strong guidance; shares up over 10% https://seekingalpha.com/news/3270919-ciena-q1-beats-estimates-issues-strong-guidance-shares-up-over-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3270919-ciena-q1-beats-estimates-issues-strong-guidance-shares-up-over-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270953\" data-ts=\"1496319441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NADL\" target=\"_blank\">NADL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270953-north-atlantic-drilling-seadrill-win-extra-time-on-rosneft-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">North Atlantic Drilling, Seadrill win extra time on Rosneft deal</a></h4><ul>     <li>North Atlantic Drilling (NYSE:<a href='https://seekingalpha.com/symbol/NADL' title='North Atlantic Drilling Ltd.'>NADL</a>) <font color='green'>+8.4%</font> and Seadrill (NYSE:<a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a>) <font color='green'>+4.3%</font> premarket after agreeing to <a href=\"http://www.upstreamonline.com/live/1272014/seadrill-nadl-extra-time-on-rosneft-pact\" target=\"_blank\">extend their closing date</a> in a framework agreement with Rosneft (<a href='https://seekingalpha.com/symbol/RNFTF' title='Rosneft Oil Company OJSC'>OTCPK:RNFTF</a>) to May 2019, amid continued western sanctions on Russia.</li><li>Under the framework deal, Rosneft was to acquire a 30% stake in NADL in exchange for land drilling rigs and cash; in a separate agreement, NADL would provide six  offshore drilling rigs to Rosneft.</li><li>NADL and SDRL can continue to market the offshore drilling rigs and enter into binding contracts with third parties.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270953\" data-linked=\"North Atlantic Drilling, Seadrill win extra time on Rosneft deal\" data-tweet=\"$NADL $NADL $SDRL - North Atlantic Drilling, Seadrill win extra time on Rosneft deal https://seekingalpha.com/news/3270953-north-atlantic-drilling-seadrill-win-extra-time-on-rosneft-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3270953-north-atlantic-drilling-seadrill-win-extra-time-on-rosneft-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270929\" data-ts=\"1496316820\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270929-casino-stocks-rally-after-strong-macau-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Casino stocks rally after strong Macau results</a></h4><ul> <li>Casino stocks are higher after the strong results out of Macau for May. The 24% year-over-year jump came in a month that included a visit by National People&rsquo;s Congress Chairman Zhang Dejiang and a tough calendar comparison.</li> <li>Channel checks indicate that the VIP segment provided much of the revenue boost.</li> <li>An early estimate from Bernstein on June revenue indicates a range of 20% to 26% growth.</li> <li>Premarket: Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) <font color='green'>+1.41%</font>, MGM Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MGM' title='MGM Resorts International'>MGM</a>) <font color='green'>+1.67%</font>, Melco Resorts &amp; Entertainment (NASDAQ:<a href='https://seekingalpha.com/symbol/MLCO' title='Melco Resorts & Entertainment Limited ADR'>MLCO</a>) <font color='green'>+2.30%</font>, Las Vegas Sands (NYSE:<a href='https://seekingalpha.com/symbol/LVS' title='Las Vegas Sands Corp.'>LVS</a>) <font color='green'>+0.20%</font>.</li><li>Sources: Barron's and Bloomberg</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3270903-macau-casino-revenue-soars-may\" target=\"_blank\">Macau casino revenue soars in May</a> (June 1)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3270929\" data-linked=\"Casino stocks rally after strong Macau results\" data-tweet=\"$WYNN $WYNN $MGM - Casino stocks rally after strong Macau results https://seekingalpha.com/news/3270929-casino-stocks-rally-after-strong-macau-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3270929-casino-stocks-rally-after-strong-macau-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270915\" data-ts=\"1496315563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270915-deere-to-buy-wirtgen-group-for-4_6b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere to buy Wirtgen Group for \u20ac4.6B</a></h4><ul><li>Deere (NYSE:<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a>) has agreed to <a href=\"https://seekingalpha.com/pr/16849056-deere-acquire-wirtgen-group-global-leader-road-construction-equipment\" target=\"_blank\">acquire</a> the Wirtgen Group, a privately-held international company that manufactures road construction equipment.</li><li>The total transaction value is approximately &euro;4.6B, including the assumption of net debt and other consideration.</li><li>Deere expects the transaction to be accretive to EPS and will likely fund the purchase from a combination of cash and new equipment operations debt financing.</li><li><a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='green'>+1.8%</font> premarket. <a href='https://seekingalpha.com/symbol/CNHI' title='CNH Industrial N.V.'>CNHI</a> <font color='green'>+1.5%</font> is also moving on the news.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270915\" data-linked=\"Deere to buy Wirtgen Group for \u20ac4.6B\" data-tweet=\"$DE $DE $CNHI - Deere to buy Wirtgen Group for \u20ac4.6B https://seekingalpha.com/news/3270915-deere-to-buy-wirtgen-group-for-4_6b?source=tweet\" data-url=\"https://seekingalpha.com/news/3270915-deere-to-buy-wirtgen-group-for-4_6b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270912\" data-ts=\"1496315422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPR\" target=\"_blank\">EXPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270912-on-express-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Express&#39; Q1 results</a></h4><ul>     <li>Express (NYSE:<a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a>) reports comparable-store sales declined 10% in <a href=\"https://seekingalpha.com/pr/16849053-express-inc-reports-first-quarter-2017-eps-line-guidance-introduces-second-quarter-guidance\" target=\"_blank\">Q1</a>.</li>     <li>E-commerce sales grew 27% to $97.6M.</li>     <li>Gross margin rate slipped 620 bps to 27.2%.</li>     <li>Merchandise margins fell 380 bps&nbsp;due to increased promotional activity.</li>     <li>SG&amp;A expense rate +90 bps to 27.9%.</li>     <li>Inventory +2% Y/Y to $287.5M.</li>     <li>Store count -4 Q/Q to 652.</li>     <li><b>Q2 Guidance</b>: Comparable sales:&nbsp;Negative&nbsp;mid single&nbsp;&nbsp;digits; Tax rate: ~31%; Interest expense, net: $0.7M; Net loss: $19M to $16M; Diluted EPS: -$0.24 to -$0.20; Adjusted EPS: -$0.03 to $0.01; Shares outstanding: 78.8M; Store&nbsp;count: 635.</li>     <li><b>FY2017 Guidance</b>: Comparable sales:&nbsp;Negative low single digits; Tax rate: ~41%; Interest expense, net: $3M; Net income: $16M to $22M; Adjusted net income: $32M to $38M; Diluted EPS: $0.21 to $0.28; Adjusted EPS: $0.41 to $0.48; Shares outstanding: 79.1M; Capex: $62M to $67M; Store count: 638.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3270912\" data-linked=\"More on Express&#39; Q1 results\" data-tweet=\"$EXPR - More on Express&#39; Q1 results https://seekingalpha.com/news/3270912-on-express-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3270912-on-express-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270906\" data-ts=\"1496315070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270906-mannkind-inks-afrezza-distribution-deal-in-brazil-shares-ahead-17-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MannKind inks Afrezza distribution deal in Brazil; shares ahead 17% premarket</a></h4><ul><li>MannKind (NASDAQ:<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>) enters into a supply and distribution <a href=\"https://seekingalpha.com/pr/16848813-mannkind-biomm-enter-distribution-agreement-afrezza-brazil\" target=\"_blank\">agreement </a>with Belo Horizonte, Brazil-based BIOMM SA for the commercialization of Afrezza (insulin human) Inhalation Powder in Brazil.</li><li>Under the terms of the contract, BIOMM will be responsible for all regulatory applications and commercial activities while MannKind will manufacture and supply the product. Specific financial terms are not disclosed.</li><li>There are an estimated 14M diabetics in the country.</li><li>Shares are up&nbsp;<font color='green'>17%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270906\" data-linked=\"MannKind inks Afrezza distribution deal in Brazil; shares ahead 17% premarket\" data-tweet=\"$MNKD - MannKind inks Afrezza distribution deal in Brazil; shares ahead 17% premarket https://seekingalpha.com/news/3270906-mannkind-inks-afrezza-distribution-deal-in-brazil-shares-ahead-17-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3270906-mannkind-inks-afrezza-distribution-deal-in-brazil-shares-ahead-17-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270899\" data-ts=\"1496314757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBMG\" target=\"_blank\">CBMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270899-cellular-bio-to-buy-back-10m-in-common-shares-shares-up-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellular Bio to buy back $10M in common shares; shares up 24%</a></h4><ul><li>The board of Cellular Biomedicine (NASDAQ:<a href='https://seekingalpha.com/symbol/CBMG' title='Cellular Biomedicine Group, Inc.'>CBMG</a>) <a href=\"https://seekingalpha.com/pr/16849024-cellular-biomedicine-group-cbmg-announces-stock-repurchase-program\" target=\"_blank\">authorizes </a>the repurchase of up to $10M in common stock through open market transactions under its 2017 Stock Repurchase Program.</li><li><strong>Update</strong>: Shares are up&nbsp;<font color='green'>24%</font>&nbsp;mid-session on double normal volume, albeit on turnover of only 75K.</li></ul><div class=\"tiny-share-widget\" data-id=\"3270899\" data-linked=\"Cellular Bio to buy back $10M in common shares; shares up 24%\" data-tweet=\"$CBMG - Cellular Bio to buy back $10M in common shares; shares up 24% https://seekingalpha.com/news/3270899-cellular-bio-to-buy-back-10m-in-common-shares-shares-up-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3270899-cellular-bio-to-buy-back-10m-in-common-shares-shares-up-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3270891\" data-ts=\"1496313632\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TECD\" target=\"_blank\">TECD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3270891-on-tech-datas-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Tech Data&#39;s Q1</a></h4><ul>     <li>Tech Data (NASDAQ:<a href='https://seekingalpha.com/symbol/TECD' title='Tech Data Corporation'>TECD</a>)&nbsp;reports net sales rose 5%&nbsp;on a constant currency basis in <a href=\"https://seekingalpha.com/pr/16849019-tech-data-corporation-reports-first-quarter-fiscal-year-2018-results\" target=\"_blank\">Q1</a>.</li>     <li>The Americas net sales increased 45% to $3.5B.</li>     <li>Europe net sales grew 12% to $4B.</li>     <li>Gross margin rate improved 0.95 bps to 5.96%.</li>     <li>Adjusted SG&amp;A expense rate +32 bps to 4.36%.</li>     <li>Adjusted operating margin rate up 64 bps to 1.61%.</li>     <li><b>Q2 Guidance</b>: Net sales: $8.55B to $8.8B; Tax rate: 31% to 33%; Adjusted EPS: $1.95 to $2.08; Shares outstanding: 38.5M.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3270891\" data-linked=\"More on Tech Data&#39;s Q1\" data-tweet=\"$TECD - More on Tech Data&#39;s Q1 https://seekingalpha.com/news/3270891-on-tech-datas-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3270891-on-tech-datas-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:40 AM </div></div></li>","count":65,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}